Results 191 to 200 of about 11,899,379 (393)

Transfusion and Risk of Infection in Canada: UPDATE 2004

open access: yesCanadian Journal of Infectious Diseases, 2004
Canadian Paediatric Society, Infectious Diseases and Immunization Committee
doaj   +1 more source

Persistent Leukoencephalopathy Following H1N1 Infection Associated With a Novel MYRF Variant (p.Gly735Asp)

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Mutations in myelin regulatory factor (MYRF) are linked to demyelinating disorders. We report a 38‐year‐old male who developed acute symmetric leukoencephalopathy mimicking a stroke following an influenza A virus infection. While clinical symptoms markedly improved with corticosteroids, MRI revealed persistent white matter lesions, contrasting
Jinghan Hu   +5 more
wiley   +1 more source

Routine Immunization Schedule: Update 2004

open access: yesCanadian Journal of Infectious Diseases, 2004
Canadian Paediatric Society, Infectious Diseases and Immunization Committee
doaj   +1 more source

Recombinant immune complexes as vaccines against infectious diseases [PDF]

open access: hybrid
Mi‐Young Kim   +3 more
openalex   +1 more source

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin   +2 more
wiley   +1 more source

The Red Book is Coming to Town

open access: yesCanadian Journal of Infectious Diseases, 2003
Canadian Paediatric Society, Infectious Diseases and Immunization Committee
doaj   +1 more source

Small but Mighty: Nanobodies in the Fight Against Infectious Diseases [PDF]

open access: gold
Wenwen Jiang   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy